Ann: FDA Outlines Pathway to Accelerated Approval for MPL in MND, page-54

The issue is PAA will require $10m plus for the next trial , so its either a Partner, Options or a CR with a CR there will be dilution across all SOI and that pulls down the SP which prevents SH exercising their options.. then in turn options themselves then pull back the SP when you near the final expiry date..which now compounds the SOI.. CR + Options = double dilution

6 of one half dozen of the other .. everyone to their own ..

Those that sold their options last week ,,, made a 600% gain ,,, nice strategy , well done , especially the person who sold 1.8m ...circa $165.000 gain..

Busy week ,, "It's the final Countdown to MND Results" Best of luck to all holders ... some peoples level of risk is being struck , some are waiting for the main course...

I'm looking forward to seeing the data and especially the way it is presented to Market ,,, hoping the data brings fresh legs to the SP.. NZT